|Min SIP Amount||₹1000|
|NAV||₹322.16 (13 Apr 2021)|
|Fund Started||07 Jan 2013|
|Fund Size||₹260 Cr|
|Stylam Industries Ltd.||FMCG||Equity||7.1%|
|Fortis Healthcare Ltd.||Healthcare||Equity||6.1%|
|Tech Mahindra Ltd.||Technology||Equity||5.3%|
|Oracle Financial Services Software Ltd.||Technology||Equity||4.7%|
|Deepak Fertilisers & Petrochemicals Corpn. Ltd.||Chemicals||Equity||3.4%|
|Tata Steel Long Products Ltd.||Metals||Equity||3.3%|
|JB Chemicals & Pharmaceuticals Ltd.||Healthcare||Equity||3.0%|
|Tata Consultancy Services Ltd.||Technology||Equity||2.8%|
|General Insurance Corporation of India Ltd.||Financial||Equity||2.7%|
Quant Active Fund Direct Growth is a Equity Mutual Fund Scheme launched by Quant Mutual Fund. This scheme was made available to investors on 07 Jan 2013. Sanjeev Sharma is the Current Fund Manager of Quant Active Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹260 Cr and the Latest NAV as of 13 Apr 2021 is ₹322.16.
The Quant Active Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to 1000. Minimum Lumpsum Investment is 5000.
The scheme aims at providing long term capital appreciation and generating income with a diversified portfolio of Large Cap, Mid Cap and Small Cap companies.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.